The Effect of Extracellular Calcium Metabolism on Aldosterone Biosynthesis in Physiological and Pathological Status
- PMID: 32403152
- DOI: 10.1055/a-1157-0511
The Effect of Extracellular Calcium Metabolism on Aldosterone Biosynthesis in Physiological and Pathological Status
Abstract
Primary aldosteronism (PA) was reported to frequently harbor not only cardiovascular diseases but also some metabolic disorders including secondary calcium metabolic diseases. Recently, the potential association between aldosterone producing cells and systemic calcium metabolism has been proposed. For instance, PA is frequently associated with hypercalciuria or hypocalcemia, which subsequently stimulates parathyroid hormone (PTH) secretion. This altered calcium metabolism in PA patients could frequently result in secondary osteoporosis and fracture in some patients. On the other hand, extracellular calcium itself directly acts on adrenal cortex and has been also proposed as an independent regulator of aldosterone biosynthesis in human adrenals. However, it is also true that both PTH and vitamin D pathways stimulate endocrine functions of adrenal cortical adenomas to co-secret both aldosterone and cortisol. Therefore, it has become pivotal to explore the potential crosstalk between aldosterone and systemic calcium metabolism. We herein reviewed recent advances in these fields.
© Georg Thieme Verlag KG Stuttgart · New York.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.J Steroid Biochem Mol Biol. 2019 Oct;193:105434. doi: 10.1016/j.jsbmb.2019.105434. Epub 2019 Jul 24. J Steroid Biochem Mol Biol. 2019. PMID: 31351131
-
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.Metabolism. 2014 Jan;63(1):20-31. doi: 10.1016/j.metabol.2013.08.016. Epub 2013 Oct 2. Metabolism. 2014. PMID: 24095631 Review.
-
Association Between Aldosterone and Parathyroid Hormone Levels in Patients With Adrenocortical Tumors.Endocr Pract. 2022 Jan;28(1):90-95. doi: 10.1016/j.eprac.2021.09.002. Epub 2021 Sep 8. Endocr Pract. 2022. PMID: 34508903
-
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):E4591-9. doi: 10.1073/pnas.1505529112. Epub 2015 Aug 3. Proc Natl Acad Sci U S A. 2015. PMID: 26240369 Free PMC article.
-
Aldosterone-Producing Cell Clusters in Normal and Pathological States.Horm Metab Res. 2017 Dec;49(12):951-956. doi: 10.1055/s-0043-122394. Epub 2017 Dec 4. Horm Metab Res. 2017. PMID: 29202494 Free PMC article. Review.
Cited by
-
Progress in Primary Aldosteronism 2019: New Players on the Block?Horm Metab Res. 2020 Jun;52(6):345-346. doi: 10.1055/a-1156-9926. Epub 2020 Jun 16. Horm Metab Res. 2020. PMID: 32544975 Free PMC article.
-
Correlation between plasma aldosterone concentration and bone mineral density in middle-aged and elderly hypertensive patients: potential impact on osteoporosis and future fracture risk.Front Endocrinol (Lausanne). 2024 May 14;15:1373862. doi: 10.3389/fendo.2024.1373862. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38808106 Free PMC article.
-
The Relationship between Renin-Angiotensin-Aldosterone System (RAAS) Activity, Osteoporosis and Estrogen Deficiency in Type 2 Diabetes.Int J Mol Sci. 2023 Jul 26;24(15):11963. doi: 10.3390/ijms241511963. Int J Mol Sci. 2023. PMID: 37569338 Free PMC article. Review.
-
Evaluating the clinical and mechanistic effects of eplerenone and amiloride monotherapy, and combination therapy with cinacalcet, in primary hyperparathyroidism: A placebo-controlled randomized trial.Clin Endocrinol (Oxf). 2023 Apr;98(4):516-526. doi: 10.1111/cen.14840. Epub 2022 Nov 8. Clin Endocrinol (Oxf). 2023. PMID: 36316798 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical